Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

50.28 +0.18 (+0.36%)

Delayed Quote Updated: 2:46 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2 3 4 5 6 7 8 9

...

37 38 Next >

Navigating the Currents: Top Sectors Primed for Growth in Q3 2025

August 27, 2025

The global economy is sailing into Q3 2025 with a blend of cautious optimism and persistent challenges. While a new tariff regime and elevated geopolitical tensions introduce elements of uncertainty,...

Via MarketMinute

Peering Into CRISPR Therapeutics's Recent Short Interest ↗

August 22, 2025

Via Benzinga

Cathie Wood's ARKK Is Beating Big Tech Like It's 2020 Again — But With A Twist ↗

August 19, 2025

Cathie Wood's ARK Innovation ETF is outperforming tech market again in 2025, driven by AI breakthroughs and the return of inflows.

Via Benzinga

Topics Artificial Intelligence ETFs

Here's How This Forgotten Healthcare Stock Could Generate Life-Changing Returns ↗

August 17, 2025

This biotech's innovative approach could pay rich dividends down the road.

Via The Motley Fool

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade ↗

August 14, 2025

Ark Invest has six main ETFs with several around for more than 10 years. A look at the top 10 holdings across the six funds and what it could mean.

Via Benzinga

Topics ETFs

Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results ↗

August 05, 2025

Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday.

Via Benzinga

Up 50% in 3 Months, Is This Stock Still a Buy? ↗

August 05, 2025

This biotech's innovative ways might eventually pay off.

Via The Motley Fool

The 3 Things That Matter for CRISPR Therapeutics Now ↗

July 29, 2025

As time marches on, the factors that could make or break this stock are becoming crystal clear.

Via The Motley Fool

Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics ↗

July 26, 2025

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

Via Benzinga

Cathie Wood Doesn't Need Tesla To Win—ARKK Delivers A Blowout While EV Giant Idles ↗

July 25, 2025

During the pandemic-fueled boom of 2020, Cathie Wood's Ark Innovation ETF (NYSE:ARKK) was one of the hottest funds on Wall Street, surging nearly 400% off its March 2020 lows. But that euphoria peaked...

Via Benzinga

Topics ETFs

3 Monster Stocks in the Making to Buy Right Now ↗

July 21, 2025

Via The Motley Fool

Independent Bank Posts Upbeat Earnings, Joins Blaize Holdings, Interactive Brokers Group And Other Big Stocks Moving Higher On Friday ↗

July 18, 2025

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

Via Benzinga

Topics Stocks

3 Monster Stocks to Hold for the Next 10 Years ↗

July 17, 2025

These companies have compelling long-term futures, but the coming decade could prove particularly exciting as each one comes into its own.

Via The Motley Fool

CRISPR Stock Surges in Recent Weeks: What's Going On? ↗

July 10, 2025

Via Benzinga

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

July 09, 2025

Via Investor Brand Network

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers

July 09, 2025

EQNX::TICKER_START (NYSE:CLDI),(NASDAQ:VRTX),(NASDAQ:IBRX),(NASDAQ:CRSP),(NASDAQ:CTMX) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Death

10 Monster Stocks to Hold for the Next 10 Years ↗

July 08, 2025

Each of these 10 businesses offers a market-leading product or service within an industry that's set to explode.

Via The Motley Fool

Cathie Wood-Led Ark Launches Buffer ETFs For Its Flagship ARKK, Analyst Says It's Like Diet Soda — 50% Loss Protection, But There's A Catch ↗

July 08, 2025

Cathie Wood's Ark Investment Management has filed plans to launch four new exchange-traded funds designed to offer downside protection for investors in its flagship ARK Innovation ETF (BATS: ARKK),...

Via Benzinga

Topics ETFs

2 Beaten-Down Stocks With Massive Upside Potential ↗

July 03, 2025

Via The Motley Fool

2 Growth Stocks to Buy Hand Over Fist in July ↗

July 02, 2025

These companies are poised to produce fireworks for your portfolio over the coming years.

Via The Motley Fool

44 Public Companies Make Time's Most Influential List: Coinbase, UFC, Nintendo, Netflix And More Stocks Investors Can Buy ↗

June 27, 2025

The 2025 TIME 100 Most Influential Companies list includes over 40 companies that investors can buy stock in.

Via Benzinga

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts ↗

June 21, 2025

Via The Motley Fool

FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering ↗

June 20, 2025

FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era exemption on federally funded research

Via Benzinga

The FDA Shake-Up Continues, And Could Impact Genetic Medicines ↗

June 20, 2025

Nicole Verdun and Rachael Anatol were placed on administration leave without explanation.

Via Investor's Business Daily

Topics Government

Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst ↗

June 18, 2025

Lilly's Verve acquisition lifts sentiment in gene editing stocks, with analysts calling it a strategic and timely move in a tough funding climate.

Via Benzinga

Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday ↗

June 17, 2025

Via Benzinga

Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover ↗

June 17, 2025

The companies were already collaborating on a handful of cardiovascular-focused gene-editing treatments.

Via Investor's Business Daily

Cathie Wood Just Flagged The Start Of A Biotech Revolution: These 2 Stocks With 10x Potential Are Leading It ↗

June 09, 2025

Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable diseases.

Via Benzinga

Topics Artificial Intelligence

The Best Stocks to Invest $1,000 in Right Now ↗

June 03, 2025

Forget the hyper-volatile, high-profile stock names. In this environment, lesser-known and less-exciting stocks are apt to bear more fruit.

Via The Motley Fool

Topics Government World Trade

The 2 Smartest Beaten-Down Biotech Stocks to Buy on the Dip ↗

June 02, 2025

Via The Motley Fool

Topics Economy

< Previous 1 2 3 4 5 6 7 8 9

...

37 38 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.